Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,075 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC.
Berger T, Brochet B, Brambilla L, Giacomini PS, Montalbán X, Vasco Salgado A, Su R, Bretagne A. Berger T, et al. Mult Scler J Exp Transl Clin. 2019 Dec 2;5(4):2055217319887191. doi: 10.1177/2055217319887191. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31832225 Free PMC article.
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome.
Hartung HP, Freedman MS, Polman CH, Edan G, Kappos L, Miller DH, Montalbán X, Barkhof F, Petkau J, White R, Sahajpal V, Knappertz V, Beckmann K, Lanius V, Sandbrink R, Pohl C; BENEFIT Study Group. Hartung HP, et al. Neurology. 2011 Aug 30;77(9):835-43. doi: 10.1212/WNL.0b013e31822c90d7. Epub 2011 Aug 17. Neurology. 2011. PMID: 21849647 Clinical Trial.
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilariño-Güell C. Sadovnick AD, et al. Among authors: berger t. G3 (Bethesda). 2016 Jul 7;6(7):2073-9. doi: 10.1534/g3.116.030841. G3 (Bethesda). 2016. PMID: 27194806 Free PMC article.
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.
Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM; BENEFIT Study Group. Kappos L, et al. Neurology. 2016 Sep 6;87(10):978-87. doi: 10.1212/WNL.0000000000003078. Epub 2016 Aug 10. Neurology. 2016. PMID: 27511182 Free PMC article. Clinical Trial.
Sodium intake and multiple sclerosis activity and progression in BENEFIT.
Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A; BENEFIT Study Group. Fitzgerald KC, et al. Ann Neurol. 2017 Jul;82(1):20-29. doi: 10.1002/ana.24965. Ann Neurol. 2017. PMID: 28556498 Free PMC article. Clinical Trial.
Serum hepcidin levels in multiple sclerosis.
Bsteh G, Haschka D, Tymoszuk P, Berek K, Petzer V, Hegen H, Wurth S, Auer M, Zinganell A, Pauli FD, Deisenhammer F, Weiss G, Berger T. Bsteh G, et al. Among authors: berger t. Mult Scler J Exp Transl Clin. 2019 Nov 4;5(4):2055217319885984. doi: 10.1177/2055217319885984. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31723437 Free PMC article.
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis.
Bsteh G, Berek K, Hegen H, Buchmann A, Voortman MM, Auer M, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Khalil M, Berger T. Bsteh G, et al. Among authors: berger t. Mult Scler J Exp Transl Clin. 2019 Nov 5;5(4):2055217319885987. doi: 10.1177/2055217319885987. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31723438 Free PMC article.
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, Gornall M, Cicconi S, Brandt A, Berek K, Berger T, Jelcic I, Gombolay G, Oliveira LM, Callegaro D, Kaneko K, Misu T, Capobianco M, Gibbons E, Karthikeayan V, Brochet B, Audoin B, Mathey G, Laplaud D, Thouvenot E, Cohen M, Tourbah A, Maillart E, Ciron J, Deschamps R, Biotti D, Rostasy K, Neuteboom R, Hemingway C, Forsyth R, Matiello M, Webb S, Hunt D, Murray K, Hacohen Y, Lim M, Leite MI, Palace J, Solomon T, Lutterotti A, Fujihara K, Nakashima I, Bennett JL, Pandit L, Chitnis T, Weinshenker BG, Wildemann B, Sato DK, Kim SH, Huda S, Kim HJ, Reindl M, Levy M, Jarius S, Tenembaum S, Paul F, Pittock S, Marignier R, Jacob A. Whittam DH, et al. Among authors: berger t. Mult Scler Relat Disord. 2020 Sep;44:102251. doi: 10.1016/j.msard.2020.102251. Epub 2020 Jun 2. Mult Scler Relat Disord. 2020. PMID: 32629363 Free PMC article.
2,075 results